flâneur

ARCH Venture Partners Interview - USA Pharma & Biopharma 2021

projects.gbreports.com · 651 words · saved by 1 readers

26/66 ARCH Venture Partners Interview KEITH CRANDELL, CO-FOUNDER & MANAGING DIRECTOR, ARCH VENTURE PARTNERS "Trying to thread together that combination of outstanding management, scientific innovation, scientific founders and then that clinical orientation in a way that allows them to work constructively and productively is the secret sauce." How has ARCH evolved its model over the years? We follow the science, which they usually tell you in business school not to do - you are supposed to look to create a product to meet the market opportunity. However, if you work with really powerful platforms, you can develop a level of confidence that there will be applications. There are other things that we added that have improved the model. Some of that includes more access to capital, so that we can continue to be a strong supporter of our portfolio companies throughout their funding lifecycles all the way through IPO. We were very strong with our strategic limited partners in the early funds

How has ARCH evolved its model over the years? We follow the science, which they usually tell you in business school not to do - you are supposed to look to create a product to meet the market opportunity. However, if you work with really powerful platforms, you can develop a level of confidence that there will be applications. There are other things that we added that have improved the model. Some of that includes more access to capital, so that we can continue to be a strong supporter of our portfolio companies throughout their funding lifecycles all the way through IPO. We were very…

saved by

related reading